OpenAI just released a report about healthcare drawn from anonymized chatbot conversations. The title could double as one of ...

In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

Doctor shortages, weak infrastructure and rising chronic disease are fuelling rapid growth in Kenya’s healthtech sector.

The Asian Development Bank, with support from the Government of Austria and research partners including Emory University, piloted wastewater-based epidemiology in Nepal and the Philippines to show how ...

In terms of liquidity and interest, the mean open interest for Arrowhead Pharma options trades today is 878.14 with a total volume of 5,476.00.

“Weighted blankets can reduce restlessness, soften racing thoughts, and reduce physical symptoms associated with anxiety, ...

Impacts of biological amendments, including waste-derived amendments that underpin soil health and agricultural ...

Nia Therapeutics announced publication in Brain Stimulation of the first in vivo validation of its Smart Neurostimulation ...

Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base ...